{"disease":{"id":"onchocerciasis","name":"onchocerciasis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07145736","title":"Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of Onchocerciasis and Other Neglected Tropical Diseases","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":52000,"lead_sponsor_name":"Kirby Institute","has_results":false},{"nct_id":"NCT05750043","title":"Effect of Onchocerciasis Elimination Measures on the Incidence of Epilepsy in Maridi, South Sudan","phase":"","overall_status":"COMPLETED","enrollment_count":17000,"lead_sponsor_name":"Universiteit Antwerpen","has_results":false},{"nct_id":"NCT04311671","title":"Safety of a Single Dose of Moxidectin Compared With Ivermectin in Individuals Living in Onchocerciasis Endemic Areas and in Individuals Living in Onchocerciasis Endemic Areas With High Levels of Lymphatic Filariasis Co-endemicity Receiving Concomitant Albendazole","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":12979,"lead_sponsor_name":"Medicines Development for Global Health","has_results":true},{"nct_id":"NCT05749653","title":"Impact of a Bi-annual CDTI on the Incidence of Epilepsy in an Onchocerciasis-endemic Area","phase":"NA","overall_status":"COMPLETED","enrollment_count":6500,"lead_sponsor_name":"Universiteit Antwerpen","has_results":false},{"nct_id":"NCT03131401","title":"Prevalence of LF Infection in Districts Not Included in LF Control Activities","phase":"","overall_status":"COMPLETED","enrollment_count":3736,"lead_sponsor_name":"Noguchi Memorial Institute for Medical Research","has_results":false},{"nct_id":"NCT07506967","title":"Early Detection and AI-Based Management of Skin-Related Neglected Tropical Diseases in Sub-Saharan Africa by Frontline Health Workers","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":2420,"lead_sponsor_name":"Kenya Medical Research Institute","has_results":false},{"nct_id":"NCT05180461","title":"Emodepside Phase II Trial for Treatment of Onchocerciasis","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":578,"lead_sponsor_name":"Drugs for Neglected Diseases","has_results":false},{"nct_id":"NCT00001230","title":"Host Response to Infection and Treatment in Filarial Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT03876262","title":"Safety and Efficacy of Annual or Biannual Doses of Moxidectin or Ivermectin for Onchocerciasis","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":323,"lead_sponsor_name":"Medicines Development for Global Health","has_results":false},{"nct_id":"NCT06070116","title":"Safety and Efficacy of Novel Combination Regimens for Treatment of Onchocerciasis","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT04049630","title":"Clinical Trial Evaluating the Safety and Efficacy of Levamisole in Loa Loa Microfilaremic Patients","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":255,"lead_sponsor_name":"Programme National de Lutte contre l'Onchocercose, Republic of the Congo","has_results":false},{"nct_id":"NCT03517462","title":"Ocular Changes After Ivermectin - (DOLF IVM/Oncho)","phase":"NA","overall_status":"COMPLETED","enrollment_count":231,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT04188301","title":"Safety and Efficacy of IDA for Onchocerciasis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":154,"lead_sponsor_name":"Washington University School of Medicine","has_results":true},{"nct_id":"NCT04913610","title":"Study to Assess Adverse Events, Change in Disease Activity and How Oral ABBV-4083 Capsules When Given Alone or In Combination With Albendazole Capsules Moves in The Body of Adult Participants With Onchocerca Volvulus Infection","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":153,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT03052998","title":"Ivermectin Treatment in Patients With Onchocerciasis-associated Epilepsy","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":91,"lead_sponsor_name":"Robert Colebunders","has_results":false},{"nct_id":"NCT04049851","title":"Clinical Trial Evaluating the Safety and Efficacy of Moxidectin 2 mg Ivermectin-controlled in Loa Loa Microfilaremic Patients","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":72,"lead_sponsor_name":"Center for Research on Filariasis and Other Tropical Diseases, Cameroon","has_results":false},{"nct_id":"NCT03962062","title":"A Pharmacokinetic and Safety Study of Moxidectin to Identify an Optimal Dose for Treatment of Children 4 to 11 Years","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Medicines Development for Global Health","has_results":true},{"nct_id":"NCT05084560","title":"Development of AWZ1066S, a Small Molecule Anti-Wolbachia Candidate Macrofilaricide Drug","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":30,"lead_sponsor_name":"Liverpool School of Tropical Medicine","has_results":false},{"nct_id":"NCT06412926","title":"A Study to Learn About How Much Emodepside Gets Absorbed in the Blood and How Food Affects Its Absorption When Given as a New Type of Tablet to Healthy Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT04035174","title":"Evaluation of the Diagnosis Performances of DEC LTS-2 Skin Patch for Onchocerciasis in Central Africa","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Center for Research on Filariasis and Other Tropical Diseases, Cameroon","has_results":false}],"total":20},"guidelines":[],"source":"Drug Landscape verified database"}